ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 482

The Link between ACPA and Erosion Development: Is ACPA Sufficient? an Association Study in Clinically Suspect Arthralgia

Robin M ten Brinck1, REM Toes2 and Annette H.M. van der Helm-van Mil1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: ACPA, inflammation and rheumatoid arthritis (RA), Rheumatoid Factor

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Anti-citrullinated protein antibodies (ACPA) associate with more severe joint erosions in rheumatoid arthritis (RA), but the underlying mechanism is unclear. Recent in vitro and murine studies indicate that ACPAs can directly activate osteoclasts leading to bone erosion and pain. This study sought evidence for this hypothesis on the human level and evaluated in arthralgia patients at risk for RA whether ACPA associated with erosions (detected by MRI) independent of inflammation, and also independent of the presence of other autoantibodies (Rheumatoid Factor, RF).

Methods:

 225 patients with Clinically Suspect Arthralgia underwent ACPA- and RF-determination and 1.5T contrast-enhanced MRI of metacarpophalangeal, wrist and metatarsophalangeal joints at baseline. MRIs were scored for presence of local inflammation and erosions.

Results:

ACPA-positive patients had higher erosion-scores than ACPA-negative patients (p=0.02; Figure Panel A). ACPA-positive patients without subclinical inflammation did not have higher erosion-scores than ACPA-negative patients (p=0.45), in contrast to ACPA-positive patients with local inflammation (p=0.001, Figure Panel B). Mediation analyses suggested that local inflammation is in the causal path of ACPA leading to higher erosion-scores. Compared to autoantibody-negative patients, ACPA-positive/RF-negative patients did not differ (p=0.41), but ACPA-positive/RF-positive patients had higher erosion-scores (p=0.001 Figure Panel C).

Conclusion:

The effect of ACPA on erosions is mediated by inflammation and is not independent of RF.


Figure. Histograms showing median erosion-scores of patients with Clinically Suspect Arthralgia comparing ACPA-positive and ACPA-negative patients (A), ACPA-positivity and -negativity in relation to the concomitant presence of  MRI-detected subclinical inflammation (B) or rheumatoid factor (C).

Legend:

Histograms showing median erosion-scores with standard deviations.

 * indicates significance at p<0.05 level, ** indicates significance of p<0.01 level, NS indicates non-significance



Disclosure: R. M. ten Brinck, None; R. Toes, None; A. H. M. van der Helm-van Mil, None.

To cite this abstract in AMA style:

ten Brinck RM, Toes R, van der Helm-van Mil AHM. The Link between ACPA and Erosion Development: Is ACPA Sufficient? an Association Study in Clinically Suspect Arthralgia [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-link-between-acpa-and-erosion-development-is-acpa-sufficient-an-association-study-in-clinically-suspect-arthralgia/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-link-between-acpa-and-erosion-development-is-acpa-sufficient-an-association-study-in-clinically-suspect-arthralgia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology